<DOC>
	<DOC>NCT00171041</DOC>
	<brief_summary>Drugs used to treat high blood pressure in adults should also be effective in treating high blood pressure in children and adolescents. This study will test the safety and efficacy of valsartan in treating high blood pressure in hypertensive children 6-16 years of age whose parent(s)/guardian(s) grant permission to participate.</brief_summary>
	<brief_title>A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>CHILDREN HAVE SYSTOLIC BLOOD PRESSURE AT A LEVEL =&gt;95th PERCENTILE FOR AGE/GENDER/HEIGHT CONSENT FROM PARENT(S)/GUARDIAN(S) MUST BE GRANTED BLOOD PESSURE IS =&gt;5% HIGHER THAN 99th PERCENTILE FOR AGE SERIOUS, CLINICALLY SIGNIFICANT FINDINGS UPON PHYSICAL EXAMINATION, AND LABORATORY AND OTHER ASSESSMENTS Other protocoldefined inclusion/exclusion criteria will also apply.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>PEDIATRIC HYPERTENSION</keyword>
	<keyword>PEDIATRIC</keyword>
	<keyword>VALSARTAN</keyword>
</DOC>